There is provided a method for improving the efficacy and/or transdermal transport of topically administered pharmaceuticals and pharmacologically active compounds, said method comprising the step of incorporating the pharmaceutical or pharmacologically active compound in a carrier comprising an eff
There is provided a method for improving the efficacy and/or transdermal transport of topically administered pharmaceuticals and pharmacologically active compounds, said method comprising the step of incorporating the pharmaceutical or pharmacologically active compound in a carrier comprising an effective amount of one or more complexes of a phosphate derivative of a lipophilic pharmaceutically acceptable compound.
대표청구항▼
1. A method for improving the efficacy and/or transdermal transport of topically administered pharmaceuticals and pharmacologically active compounds, said method comprising the step of incorporating the pharmaceutical or pharmacologically active compound in a carrier comprising an effective amount o
1. A method for improving the efficacy and/or transdermal transport of topically administered pharmaceuticals and pharmacologically active compounds, said method comprising the step of incorporating the pharmaceutical or pharmacologically active compound in a carrier comprising an effective amount of one or more complexes of a phosphorylated lipophilic pharmaceutically acceptable compound; from the group consisting of laurylaminodipropionic acid tocopheryl monophosphate, laurylaminodipropionic acid tocopheryl diphosphate, and mixtures thereof. 2. The method according to claim 1, wherein the effective amount of the one or more complexes of the phosphorylated lipophilic pharmaceutically acceptable compound is in the range from 1 to 90% w/w of the total weight of the carrier. 3. The method according to claim 2 wherein the effective amount is in the range from 40 to 90% w/w of the total weight of the carrier. 4. The method according to claim 3 wherein the effective amount is in the range from 45 to 75% w/w of the total weight of the carrier. 5. The method according to claim 4 wherein the effective amount is in the range from 50 to 60% w/w of the total weight of the carrier. 6. The method according to claim 2 wherein the effective amount is in the range from 1 to 15% w/w of the total weight of the carrier. 7. The method according to claim 2 wherein the effective amount is in the range from 1 to 10% w/w of the total weight of the carrier. 8. The method according to claim 7 wherein the effective amount is in the range from 5 to 10% w/w of the total weight of the carrier. 9. The method according to claim 1, wherein the carrier further comprises excipients selected from the group consisting of solvents, surfactants, emollients, preservatives, colorants, fragrances and mixtures thereof. 10. The method according to claim 1, wherein the pharmaceutical or pharmacologically active compound is selected from the group consisting of morphine, atropine, estradiol, and testosterone. 11. The method of claim 1 wherein the pharmacologically active compound is selected from the group consisting of narcotic analgesics including morphine and levorphanol, non narcotic analgesics including codeine and acetominophen, corticosteroids such as cortisone, anesthetics including propofol, antiemetics including scopolamine, sympathomimetic drugs including adrenaline and dopamine, antiepileptic drugs including fosphenytoin, anti-inflammatory drugs including ibuprofen, thyroid hormones and antithyroid drugs including thyroxine, phytochemicals including α-bisabolol, eugenol, silybin, soy isoflavones, iridoid glycosides including aucubin and catapol, sesquiterpene lactones including pseudoguaianolide from Arnica chamissonis, terpenes including rosmarinic acid and rosmanol, phenolic glycosides including the salicylates salicin, saligenin and salicylic acid, triterpenes taxasterol or α-lactucerol, and isolactucerol, taraxacoside, hydroquinones including arbutin, phenylalkanones including gingerols and shagaols, hypercin, and acylphloroglucides including xanthohumol, lupulone, humulone and 2-methylbut-3-en-2-ol.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (79)
Terren Nadia,FRX ; Michelet Jacques,FRX ; Perrin Martine,FRX, Acidic composition based on lipid vesicles and its use in topical application.
Lhner Manfred (Bonn DEX) Posselt Klaus (Bonn DEX) Vogtle-Junkert Ute (Alfter DEX) Wagener Hans H. (Meckenheim DEX), Agents for the treatment of severe pain and preparation of said agents.
Challis Brian Christopher,GB3 ; Guthrie Walter Graham,GB3 ; Roper David Vincent,GB3 ; Trew David Frank,GB3, Chemical compositions for inhibiting nitrosation reaction in toiletries and cosmetics.
Kenneth B Kirby ; Berno I. R. Pettersson, Jr., Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof.
Lubkin Virginia (One Blackstone Pl. New York NY 10471), Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and appli.
Belly Robert T. (Ithaca NY) Scensny Patricia M. (Rochester NY) Wu Annie L. (Penfield NY) Chen Chung-yuan (Rochester NY), Hydrolyzable compounds which release electron transfer agents and analytical use of same.
Sanjay Kumar IN; Rashmita Sahoo IN; Paramvir Singh Ahuja IN, Isozyme of autoclavable superoxide dismutase (SOD), a process for the identification and extraction of the SOD in cosmetic, food and pharmaceutical compositions.
Palepu, Nagesh; Kessler, Dean; Tustian, Alexander K.; Quay, Steven C.; Constantinides, Panayiotis P.; Lambert, Karel J., Method for treating colorectal carcinoma using a taxane/tocopherol formulation.
Ito Shinobu,JPX ; Ogata Eiji,JPX, Method of administering vitamin E to animals and compositions containing tocopheryl phosphates and salts thereof for animals.
Lucas Juliet Marie ; Trinh Toan ; Dodd Michael Thomas ; Bartolo Robert Gregory, Methods for controlling environmental odors on the body using compositions comprising uncomplexed cyclodextrins.
Uphues Guenter (Monheim DEX) Ploog Uwe (Haan DEX) Bischof Klaudia (Werne DEX), Process for the production and isolation of monoalkyl phosphoric acid esters.
Schor Joseph M. (Locust Valley NY) Nigalaye Ashok (Elmhurst NY) Gaylord Norman G. (New Providence NJ), Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose.
Manning Mark C. ; Randolph Theodore W. ; Shefter Eli ; Falk ; III Richard F., Solubilization of pharmaceutical substances in an organic solvent and preparation of pharmaceutical powders using the s.
Bernard Dominique (Paris FRX) Nguyen Quang Lan (Antony FRX), Stabilized cosmetic or dermatological composition containing several precursors of the same active agent in order to max.
Bob G. Sanders ; Kimberly Kline ; Laurence Hurley ; Robb Gardner ; Marla Menchaca ; Weiping Yu ; Puthucode N. Ramanan ; Shenquan Liu ; Karen Israel, Tocopherols, tocotrienols, other chroman and side chain derivatives and uses therof.
Kurihara-Bergstrom Tamie (New City NY) Liu Puchun (Storrs CT), Transdermal administation of ionic pharmaceutically active agents via aqueous isopropanol.
Weissman Donald L. ; Rosenbaum Jerry, Treatment and prevention of cardiovascular diseases with help of aspirin, antioxidants, niacin, and certain B vitamins.
Meybeck Alain (Courbevoie FRX) Bonte Frederic (Courbevoie FRX) Marechal Christian (Paris FRX), Use of a
상세보기
Meybeck Alain (Courbevoie FRX) Dumas Marc (Colombes FRX) Bonte Frederic (Courbevoie FRX) Marechal Christian (Paris FRX), Use of a tocopherol phosphate or one of its derivatives for the preparation of cosmetic or pharmaceutical compositions a.
Meybeck Alain (Courbevoie FRX) Dumas Marc (Colombes FRX) Bonte Frederic (Courbevoie FRX) Marechal Christian (Paris FRX), Use of a tocopherol phosphate or one of its derivatives, for the preparation of cosmetic or pharmaceutical compositions.
Hong Jong Eon,KRX ; Lee Ki Hwa,KRX ; Cho Jun Chul,KRX ; Lee Jang Sob,KRX ; Lee Jung No,KRX ; Chun Ji Min,KRX ; Jang Dong Il,KRX ; Lee Ok Sob,KRX ; Lee Sang Rhin,KRX, Water-in-stable L-ascorbic acid derivative and a method for preparation thereof, and a skin-whitening cosmetic compositi.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.